Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

Minimal/measurable residual disease (MRD) monitoring is progressively changing the management of hematologic malignancies. The possibility of detecting the persistence/reappearance of disease in patients in apparent clinical remission offers a refined risk stratification and a treatment decision mak...

Descripción completa

Detalles Bibliográficos
Autores principales: Assanto, Giovanni Manfredi, Del Giudice, Ilaria, Della Starza, Irene, Soscia, Roberta, Cavalli, Marzia, Cola, Mattia, Bellomarino, Vittorio, Di Trani, Mariangela, Guarini, Anna, Foà, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043164/
https://www.ncbi.nlm.nih.gov/pubmed/36998457
http://dx.doi.org/10.3389/fonc.2023.1152467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043164/
https://www.ncbi.nlm.nih.gov/pubmed/36998457
http://dx.doi.org/10.3389/fonc.2023.1152467

Ejemplares similares